
SPECIAL "L&M-AH" ISSUE
DEDICATED TO THE FABULOUS STORY OF
THE HYALURONIC ACID
CONSULT THE FLIPBOOK OF "L&M-AH"
L&M INTERVIEWS
WHAT IS THE STATE OF HYALURONIC ACID RESEARCH AND DEVELOPMENT?
Michel CHERON
President and CEO, VIVACY Group
interviewed by
Pr Albert Claude BENHAMOU
Editor of "L&M" magazine
Chairman Michel CHERON
The future for Vivacy will always be hyaluronic acid.
Pr Albert Claude BENHAMOU
Mr. Chairman, it is a great honor for us, as editors of “Look & Medecine”, to present this special issue dedicated to the development of hyaluronic acid, which is at the heart of Vivacy's industrial research and development of medical applications for hyaluronic acid.
Can you tell us about Vivacy's current development in this sector?
Chairman Michel CHERON
First of all, dear Professor, I'd like to thank you for approaching us to produce this document, because it's true that very few media talk about hyaluronic acid as a medical device.
There's a lot of talk in the press and media about hyaluronic acid in general, but very little about the molecule itself, which is a fantastic molecule used in many medical fields today.
At Vivacy we use this raw material to produce our injectable gels with medical-grade quality.
Product realization and performance then lie in the way the gels are formulated. We have a patent (IPN-Like) covering all our know-how.
These are tissue-injectable medical devices that are subject to new European regulations (MDR) aimed at strengthening product monitoring and patient safety....
HYALURONIC ACID RESEARCH
CONTENTS OF THE SPECIAL ISSUE LM-AH "
THE NOVEL OF RESEARCH AND DEVELOPMENT
THE HYALURONIC ACID
AH'S FLAGSHIP CLINICAL APPLICATIONS
THE AUTHORS OF "LOOK ET MEDECINE" MAGAZINE
VIVACY GROUP SUPPORTS L&M

THEY COLLABORATE AT L&M

SEE AND REVIEW REPLAYS
BACK ISSUES OF "L&M
INDUSTRIAL LABORATORIES SUPPORT LOOK ET MEDECINE MAGAZINE
THEY COLLABORATE AT L&M
